Clinical trial

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

NCT00485498

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-04-01

PhasePHASE4

Study timeline

Study start (unknown)2003-04-01Date precision: month

Registry last updated2007-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Olanzapine HydrochlorideDRUG

RisperidoneDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00485498 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.